Navigating the 2025 Patent Cliff: Strategic Value Creation in the Global Generic Pharmaceuticals Market
The Generic Pharmaceuticals Market has entered a period of unprecedented structural change. As we move through 2025, the industry is no longer defined merely by high-volume, low-margin manufacturing. Instead, it has become a sophisticated arena where bioequivalence, digital integration, and strategic “patent cliff” navigation dictate market leadership. For B2B stakeholders—from active pharmaceutical ingredient (API) suppliers … Read more